Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants
Not Applicable
Completed
- Conditions
- Breast Reconstruction
- Interventions
- Device: Natrelle(TM) Silicone-Filled Breast Implants
- Registration Number
- NCT00691327
- Lead Sponsor
- Allergan Medical
- Brief Summary
Safety and effectiveness of Natrelle™ Cohesive Round Silicone-Filled Breast Implants in women undergoing primary reconstruction or revision of existing breast implants.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 84329
Inclusion Criteria
- Females of any age for which breast reconstruction is considered appropriate (Patients under 18 years old require parental/legal guardian consent to participate.
- Females seeking revision augmentation or revision reconstruction, where problems exist
- Have any of the following conditions or situations present:
- Post mastectomy surgical removal of the breast for cancer or other disease;
- Post trauma or post surgery where there was total or partial removal of the breast resulting in significant deformity;
- Severe ptosis requiring reconstruction;
- Any congenital or acquired discrepancy in breast size such as to represent a significant physical deformity.
- Adequate tissue available to cover implants.
- Saline-filled implants are not an appropriate choice.
Exclusion Criteria
- Advanced fibrocystic disease considered to be premalignant without accompanying subcutaneous mastectomy.
- Existing carcinoma of the breast, without mastectomy.
- Abscess of infection in the body at the time of enrollment.
- Pregnant or nursing.
- Have any disease, including uncontrolled diabetes, which is clinically known to impact wound healing ability.
- Show tissue characteristics which are clinically incompatible with mammaplasty.
- Have, or under treatment for any condition which, in the opinion of the surgeon, may constitute an unwarranted surgical risk.
- Are not willing to undergo further surgery for revision, if medically required.
- Diagnosis of lupus or scleroderma.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 3 Natrelle(TM) Silicone-Filled Breast Implants Revision-augmentation 1 Natrelle(TM) Silicone-Filled Breast Implants Primary reconstruction 2 Natrelle(TM) Silicone-Filled Breast Implants Revision-reconstruction
- Primary Outcome Measures
Name Time Method Local Complications 5 years By patient risk of complications occurring in at least 5% of patients in 1 or more cohorts
- Secondary Outcome Measures
Name Time Method Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale 5 years Satisfaction score on a 5-point scale, where 1 is definitely dissatisfied and 5 is definitely satisfied